In this paper we investigate the Quantum Brownian motion of a point particle induced by quantum vacuum fluctuations of a massless scalar field in (3 + 1)-dimensional Minkowski spacetime with distinct conditions (Dirichlet, Neumann, mixed and quasiperiodic). The modes of the field are confined and compactified to a finite length region, which consequently provides a natural measure scale for the system. Useful expressions for the Wightman function have been obtained, which allow us to calculate analytical expressions for the velocity dispersion in all condition cases considered. We also obtain expressions for the velocity dispersion in the short and late time regimes. Finally, we exhibit some graphs in order to show the behavior of the velocity dispersions, discussing important divergencies that are present in our results.
In this paper we investigate the Quantum Brownian motion of a point particle induced by quantum vacuum fluctuations of a massless scalar field in (3 + 1)-dimensional Minkowski spacetime with distinct conditions (Dirichlet, Neumann, mixed and quasiperiodic). The modes of the field are confined and compactified to a finite length region, which consequently provides a natural measure scale for the system. Useful expressions for the Wightman function have been obtained, which allow us to calculate analytical expressions for the velocity dispersion in all condition cases considered. We also obtain expressions for the velocity dispersion in the short and late time regimes. Finally, we exhibit some graphs in order to show the behavior of the velocity dispersions, discussing important divergencies that are present in our results.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.